We named our company ELGAN Pharma, as we are dedicated to improving outcome for babies who are Extremely Low Gestational Age Newborns (ELGANs). This means they are born more than 3 months before term. 

​

Premature birth is the number one cause of newborn deaths. With improved standard-of-care worldwide, survival rate increases, leading to the need of improving outcome and quality of life.   

​

 

ELGAN Pharma is a neonatology-focused biotechnology company, dedicated to developing safe tailored therapies to address medical problems and developmental difficulties that are common in babies born very early.

Biotechnology

Health Care

Pharmaceutical

Therapeutics

��

ELGAN Pharma

Org chart

Similar companies

��������

ELGAN Pharma

Org chart

Similar companies

��